Biosimilars

The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

Close of up of an older woman's eye | Image credit: Syda Productions - stock.adobe.com
First Aflibercept Biosimilars Approved in US

May 20th 2024

The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). However, patent litigation has left it unclear when the biosimilars will come to market.

AJMC
Budget Impact Analysis of Biosimilar Natalizumab in the US

May 17th 2024

Woman sitting on bed with back pain illustrated by a highlighted spine | Image credit: WavebreakMediaMicro - stock.adobe.com
Radiographic Progression Low for High-Risk Patients With axSpA on Both Secukinumab and an Adalimumab Biosimilar

April 12th 2024

FDA approval stamp in red | Image credit: chrisdorney - stock.adobe.com
FDA Approves First 2 Denosumab Biosimilars

March 5th 2024

Doctor stacking wooden blocks with health care icons | image credit: REDPIXEL - stock.adobe.com
Navigating the Biosimilar Frontier: Opportunities and Challenges in 2024

January 14th 2024

CH LogoCenter for Biosimilars Logo